Nawaporn Assawasaksakul1, Worawan Sirichana2, Waraporn Joosri1,3, Onanong Kulaputana4, Sukanya Eksakulkla5, Chutima Ketanun1,3, Piyawan Kittiskulnam1, Maythinee Chantadisai6, Kullaya Takkavatakarn1, Paweena Susantitaphong1, Kearkiat Praditpornsilpa1, Somchai Eiam-Ong1, Khajohn Tiranathanagul7. 1. Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society and Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. 2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society and Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. 3. Department of Nursing, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand. 4. Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. 5. Department of Physical Therapy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. 6. Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. 7. Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society and Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. Khajohn.T@chula.ac.th.
Abstract
PURPOSE: The mortality of dialysis patients treated with high-volume online hemodiafiltration (OL-HDF) is better than hemodialysis, but is still higher than healthy population. Low daily physical activity increases cardiovascular mortality. Addition of intradialytic exercise (IDX) program might improve physical activity and health status in OL-HDF patients. This pilot open-labeled randomized-controlled trial was conducted to evaluate the effects of IDX on physical activity and other clinical parameters in OL-HDF patients. METHODS: Twelve OL-HDF patients were randomized into control (n = 6) or IDX (n = 6) groups. The subjects in IDX group were trained to exercise using a cycle ergometer for 60 min during each OL-HDF session. Physical activity measured as daily step count using a wrist-worn triaxial accelerometer, physical fitness, or cardiorespiratory fitness assessed by VO2max and other physical performance tests, lean body mass determined by the Dual-energy X-ray absorptiometry (DXA), quality of life (QOL), and various parameters were compared between baseline and 6 months. RESULTS: The baseline physical activity status was comparable. Following 6-month IDX, the physical activity was significantly improved in IDX group [+ 1048.79 (+ 741.50, + 2792.54) vs. - 362.06 (- 1626.82, - 167.47) steps/day, p = 0.01], while physical fitness and QOL were unchanged. The lean body mass parameters were preserved in the IDX group while seemed to decrease in the control group. Serum albumin was significantly increased in the IDX group (p = 0.01). The hemoglobin changes were significantly better (p = 0.01) and the erythropoietin resistance index was significantly lower in the IDX group (p = 0.03). Phosphate reduction was significantly greater in the IDX group (p = 0.04). CONCLUSIONS: IDX could improve physical activity and other metabolic parameters in OL-HDF patients and these might contribute to further improvement in clinical and survival outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Registration: NCT03353844.
PURPOSE: The mortality of dialysis patients treated with high-volume online hemodiafiltration (OL-HDF) is better than hemodialysis, but is still higher than healthy population. Low daily physical activity increases cardiovascular mortality. Addition of intradialytic exercise (IDX) program might improve physical activity and health status in OL-HDF patients. This pilot open-labeled randomized-controlled trial was conducted to evaluate the effects of IDX on physical activity and other clinical parameters in OL-HDF patients. METHODS: Twelve OL-HDF patients were randomized into control (n = 6) or IDX (n = 6) groups. The subjects in IDX group were trained to exercise using a cycle ergometer for 60 min during each OL-HDF session. Physical activity measured as daily step count using a wrist-worn triaxial accelerometer, physical fitness, or cardiorespiratory fitness assessed by VO2max and other physical performance tests, lean body mass determined by the Dual-energy X-ray absorptiometry (DXA), quality of life (QOL), and various parameters were compared between baseline and 6 months. RESULTS: The baseline physical activity status was comparable. Following 6-month IDX, the physical activity was significantly improved in IDX group [+ 1048.79 (+ 741.50, + 2792.54) vs. - 362.06 (- 1626.82, - 167.47) steps/day, p = 0.01], while physical fitness and QOL were unchanged. The lean body mass parameters were preserved in the IDX group while seemed to decrease in the control group. Serum albumin was significantly increased in the IDX group (p = 0.01). The hemoglobin changes were significantly better (p = 0.01) and the erythropoietin resistance index was significantly lower in the IDX group (p = 0.03). Phosphate reduction was significantly greater in the IDX group (p = 0.04). CONCLUSIONS: IDX could improve physical activity and other metabolic parameters in OL-HDF patients and these might contribute to further improvement in clinical and survival outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Registration: NCT03353844.
Authors: K L Johansen; G M Chertow; A V Ng; K Mulligan; S Carey; P Y Schoenfeld; J A Kent-Braun Journal: Kidney Int Date: 2000-06 Impact factor: 10.612
Authors: Sanne A E Peters; Michiel L Bots; Bernard Canaud; Andrew Davenport; Muriel P C Grooteman; Fatih Kircelli; Francesco Locatelli; Francisco Maduell; Marion Morena; Menso J Nubé; Ercan Ok; Ferran Torres; Mark Woodward; Peter J Blankestijn Journal: Nephrol Dial Transplant Date: 2015-10-22 Impact factor: 5.992
Authors: Pablo Molina; Belén Vizcaíno; Mariola D Molina; Sandra Beltrán; Mercedes González-Moya; Antonio Mora; Cristina Castro-Alonso; Julia Kanter; Ana I Ávila; José L Górriz; Nuria Estañ; Luis M Pallardó; Denis Fouque; Juan J Carrero Journal: Nephrol Dial Transplant Date: 2018-07-01 Impact factor: 5.992
Authors: Bruce M Robinson; Tadao Akizawa; Kitty J Jager; Peter G Kerr; Rajiv Saran; Ronald L Pisoni Journal: Lancet Date: 2016-05-22 Impact factor: 79.321
Authors: Daniel S March; Thomas J Wilkinson; Thomas Burnell; Roseanne E Billany; Katherine Jackson; Luke A Baker; Amal Thomas; Katherine A Robinson; Emma L Watson; Matthew P M Graham-Brown; Arwel W Jones; James O Burton Journal: Nutrients Date: 2022-04-27 Impact factor: 6.706